Healthy high growth potential

Results

1515

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1515 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AGP
€7.030.9%-10.2%€128.2m€8.5725.839.1%n/aCapital Goods
LPK
€14.456.3%74.1%€353.4m€22.753.6116.6%0%Tech
AAZ
UK£3.850.7%133.3%UK£440.2mUK£5.6833.425.9%0.8%Materials
KEBNI B
SEK 1.03-1.8%-56.4%SEK 282.3mSEK 1.252.590.9%n/aTech
FWRY
ج.م18.93-0.3%47.3%ج.م64.5bج.م22.4524.227.3%n/aDiversified Financials
WAYS
SEK 39.703.9%-0.3%SEK 348.1mSEK 58.00211.278.5%0%Tech
CDR
zł253.806.8%3.0%zł25.3bzł230.6149.139.0%0.4%Media
AXSM
US$211.04-9.9%103.7%US$10.9bUS$282.3215.357.0%n/aPharmaceuticals & Biotech
NVDA
US$206.644.9%15.9%US$5.0tUS$302.8331.422.8%0.5%Semiconductors
RHM
€1,175.008.1%-33.6%€54.7b€1,697.8552.130.1%1.0%Capital Goods
LITE
US$779.8919.6%621.1%US$60.7bUS$1,104.89138.256.5%n/aTech
CRDO
US$218.3513.6%98.0%US$40.7bUS$279.2986.227.7%n/aSemiconductors
CORT
US$112.8019.8%60.1%US$12.2bUS$135.25224.744.8%n/aPharmaceuticals & Biotech
MDGL
US$482.00-10.5%42.2%US$11.1bUS$682.938.763.7%n/aPharmaceuticals & Biotech
SAUD3
R$16.097.7%30.8%R$47.0bR$17.2783.342.0%5.1%Healthcare
MOD
US$195.92-5.8%39.4%US$10.4bUS$310.2972.251.3%n/aCapital Goods
2368
NT$897.0010.9%144.7%NT$453.3bNT$1,576.8840.038.2%1.1%Tech
SAATVIKGL
₹426.30-2.6%n/a₹54.2b₹542.5015.239.6%n/aSemiconductors
543273
₹2,527.750.3%198.8%₹61.8b₹2,500.0078.453.9%n/aTransportation
300432
CN¥16.094.6%25.2%CN¥27.5bCN¥34.4054.360.7%0.6%Automobiles
2480
HK$14.00-0.6%-39.5%HK$2.8bHK$31.003.677.1%n/aPharmaceuticals & Biotech
325
HK$52.1511.2%-55.4%HK$12.8bHK$77.7817.522.5%n/aConsumer Durables
301345
CN¥246.502.4%61.4%CN¥26.9bCN¥320.3529.731.5%1.2%Automobiles
001389
CN¥152.681.3%140.8%CN¥69.5bCN¥248.6761.832.7%0.4%Tech
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St